EAU Events
| 9th ESOU: Gene therapy shows promise in non-muscle invasive bladder cancer | ||
 | Gene therapy shows promise in the treatment of non muscle invasive bladder cancer with current trials indicating that the gene therapy approach might offer less toxic side effects, according to Prof. Seth Lerner who spoke on the subject during the 9th EAU Section of Oncological Urology (ESOU) Meeting held this weekend in Hamburg, Germany. | |
| ||
| 9th ESOU: Debates on urothelial cancer, non-muscle invasive disease | ||
 | The second plenary session in the 9th Meeting of the EAU Section of Oncological Urology (ESOU) which opened in Hamburg, Germany, yesterday tackled issues in bladder cancer, particularly in non-muscle invasive disease, in three debate sessions that covered cystoscopy techniques, medical therapy and cystectomy. | |
| ||
| No convincing evidence on supplements to reduce prostate cancer risks | ||
 | There is still no sufficient or strong evidence on dietary or nutritional supplements in the prevention of prostate cancer with recent studies still showing scant proof that vitamins like selenium, Vitamins C or E help in reducing prostate tumours. | |
| ||
| 9th ESOU Meeting re-examines prostate cancer issues on screening, biopsies and imaging | ||
 | The issue of prostate cancer screening remains a much-discussed topic but recent studies are proving that screening decreases prostate cancer mortality, according to J. Hugosson who lectured during the three-day 9th ESOU (EAU Section of Oncological Urology) Meeting which opened today in Hamburg, Germany. | |
| ||
| ESOU’s Hamburg meeting: a comprehensive update on urological cancers | ||
 | A varied and comprehensive update on prostate, renal, bladder, penile and testis cancers will be presented and closely examined at the 9th Meeting of the EAU Section of Urological Oncology (ESOU) to be held in Hamburg, Germany, from April 20 to 22. | |
| ||
| Get ready for the European Urology Forum 2012 | ||
 | On February 4-7, Davos is hosting the European Urology Forum 2012. Taking place mere weeks before the Annual EAU Congress, the Forum has an identity all of its own. The meeting strives to look beyond established boundaries, and the Urological Challenge that takes place over the course of the Forum’s days is a unique chance for young urologists to prove themselves before a panel of experts. | |
| ||
| Is your smartphone congress-ready? | ||
 | As of this week, the iPhone App Store and Android Market feature the EAU Congress app, so don’t forget to download it! The congress is a highly dynamic event, so having all the info about the sessions and the exhibition at your fingertips is a welcome time-saver. | |
| ||
| Meeting in Davos to offer a panoramic overview of urology | ||
 | The first week of February will bring together European experts to discuss a wide range of subjects in urology, to question current developments and to share insights on the budding trends in science and practice. The European Urology Forum 2012 – Challenge the Experts is a meeting which proudly stands out as one of the most stimulating and forward-looking gatherings in the field. The format of this event encourages an open discussion on both debatable issues and established patterns of work, giving plenty of opportunity to look outside the box and to identify potential areas of development. | |
| ||
| PCa: The train has left | ||
.jpg) | Prostate cancer management was covered extensively in the course of two sessions during last week’s 3rd European Multidisciplinary Meeting on Urological Cancers. The first session hosted two debates and a presentation by Prof. N. Wernert (DE) on the new developments in the pathology of this disease. He focused his lecture on progression tissue microarray, Ki-67 research, DNA-methylation and T2-ERG studies, stating however, that no molecular signature has to date outperformed the clinical parametres. | |
| ||
| Kidney cancer: Every minute counts | ||
 | The 3rd European Multidisciplinary Meeting on Urological Cancers (EMUC) raised a vast array of controversial issues in onco-urology and offered essential updates, providing common ground for building bridges across disciplines. | |
| ||
1 2
